ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/NSW/2228-Miranda-Southside-Cancer-Care-Centre
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
10
trial(s) found.
NCT06956690
Advanced
Phase 1 / Phase 2
Recruiting
A First-in-Human, Open-label, Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With Advanced-Stage, Relapsed/Refractory HER3-Expressing Solid Tumors (
HMBD-501-101
)
ENV-501
anti-ERBB3 antibody-drug conjugate
cancer therapy
cancer therapy,ERBB3-targeting
immuno-oncology therapy,ERBB3-targeting
Breast cancer
Melanoma
Non-small cell lung cancer
NSW
2228 - Miranda - Southside Cancer Care Centre
2560 - Campbelltown - Macarthur Cancer Therapy Centre - Campbelltown Hospital
NCT06926075
Advanced
Phase 1 / Phase 2
Recruiting
An Adaptive Phase I/II Study of Kesonotide, a Novel hGIIA-vimentin Inhibitor, in Participants With Solid Tumours (
ADVICE
)
hGIIA-vimentin inhibitor
Breast cancer
Glioblastoma
Lung cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Skin cancer
NSW
2170 - Liverpool - Liverpool Hospital
2217 - Kogarah - St George Private Hospital
2228 - Miranda - Southside Cancer Care Centre
NCT06815575
Advanced
Phase 1
Recruiting
A Two-part Phase 1 Open-label Safety and Pharmacokinetic Study of Intravenous RC220 in Combination With Doxorubicin in Adult Patients With Solid Tumours. (
RAC-010
)
anthracycline
antimetabolite
Solid tumour
NSW
2228 - Miranda - Southside Cancer Care Centre
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
2259 - Wyong - Wyong Hospital
NCT05981703
Advanced
Phase 1
Recruiting
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors (
BGB-A317-26808-101
)
HPK1 inhibitor
anti-PD-1 monoclonal antibody
Solid tumour
NSW
2109 - North Ryde - Macquarie University Hospital
2228 - Miranda - Southside Cancer Care Centre (COMPLETED)
SA
5037 - Kurralta Park - Icon Cancer Centre Adelaide
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NZ
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research
NCT05914116
Advanced
Phase 1 / Phase 2
Recruiting
A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors (
DB-1311-O-1001
)
anti-B7H3 antibody-drug conjugate
Solid tumour
NSW
2031 - Randwick - Scientia Clinical Research Ltd
2050 - Camperdown - Chris O'Brien Lifehouse
2109 - North Ryde - Macquarie University Hospital
2139 - Concord - Concord Repatriation General Hospital
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2228 - Miranda - Southside Cancer Care Centre
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2305 - New Lambton Heights - John Hunter Children's Hospital
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
4224 - Tugun - Genesis Care Tugun - John Flynn Private Hospital
4575 - Birtinya - Sunshine Coast University Hospital
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NCT05533697
Advanced
Phase 1 / Phase 2
Recruiting
Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors (
mRNA-4359-P101
)
mRNA personalised cancer vaccine,IDO/PD-L1-targeting
Solid tumour
NSW
2065 - Wollstonecraft - Melanoma Institute Australia - The Poche Centre
2228 - Miranda - Southside Cancer Care Centre
VIC
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
WA
6009 - Nedlands - One Clinical Research
NCT05267626
Advanced
Phase 1 / Phase 2
Recruiting
A Phase 1/2, First-in-Human, Open Label, Dose Escalation and Expansion Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer (
CP-AU-007-01
)
anti-IL-2 monoclonal antibody
Cancer
Cutaneous melanoma
Non-small cell lung cancer
Solid tumour
NSW
2228 - Miranda - Southside Cancer Care Centre
VIC
3004 - Melbourne, Southbank - Alfred Health
3021 - St Albans - Western Health - Sunshine Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
3168 - Clayton - Monash Medical Centre
3199 - Frankston - Peninsula Health Frankston Hospital
SA
5042 - Bedford Park - Southern Oncology Clinical Research Unit
NCT04862663
Advanced
Phase 3
Recruiting
A Phase Ib/III, Open-label, Randomised Study of Capivasertib Plus CDK4/6 Inhibitors and Fulvestrant Versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (
CAPItello-292
)
pan-AKT inhibitor
selective estrogen receptor degrader
Breast cancer
NSW
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2076 - Wahroonga - Sydney Adventist Hospital (WITHDRAWN)
2228 - Miranda - Southside Cancer Care Centre (WITHDRAWN)
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
ACTRN12623000956606
Advanced
Phase 1
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacology, and Preliminary Efficacy of AT-0174 in Subjects with Advanced Solid Malignancies (
Australia
)
dual IDO/TDO inhibitor
Solid tumour
NSW
2228 - Miranda - Southside Cancer Care Centre
VIC
3066 - Epping - Northern Hospital
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital
QLD
4575 - Birtinya - Sunshine Coast University Hospital
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
ACTRN12621001537842
Advanced
Phase 1 / Phase 2
Recruiting
Safety and Efficacy of NOX66 in combination with Nivolumab for patients with solid tumours – a pilot study (IONIC-1). (
NOX66-IS-002--CA209-66P,
)
anti-PD-1 monoclonal antibody
idronoxil suppository
Solid tumour
NSW
2076 - Wahroonga - Sydney Adventist Hospital
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2217 - Kogarah - St George Hospital
2228 - Miranda - Southside Cancer Care Centre
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (10)
Recruitment Country and State
NSW (10)
WA (4)
SA (3)
VIC (3)
QLD (2)
NZ (1)
Phase
Phase 1 (3)
Phase 1 / Phase 2 (6)
Phase 3 (1)
Trial Type
Advanced (10)
Cancer Therapy Class
PD-1
40%
PD-1/PD-L1
40%
IDO
20%
PD-L1
20%
ERBB3
10%
hGIIA-vimentin
10%
HPK1
10%
AR
10%
B7H3
10%
CYP17A1
10%
SMO
10%
androgen axis
10%
CTLA4
10%
IL-2
10%
AKT
10%
CDK4
10%
CDK6
10%
ER
10%
oestrogen axis
10%
TDO
10%
Facility
2228 - Miranda - Southside Cancer Care Centre (10)
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (3)
2109 - North Ryde - Macquarie University Hospital (2)
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre (2)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (2)
4575 - Birtinya - Sunshine Coast University Hospital (2)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (2)
2076 - Wahroonga - Sydney Adventist Hospital (2)
2560 - Campbelltown - Macarthur Cancer Therapy Centre - Campbelltown Hospital (1)
2170 - Liverpool - Liverpool Hospital (1)
2217 - Kogarah - St George Private Hospital (1)
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital (1)
2259 - Wyong - Wyong Hospital (1)
5037 - Kurralta Park - Icon Cancer Centre Adelaide (1)
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research (1)
2031 - Randwick - Scientia Clinical Research Ltd (1)
2050 - Camperdown - Chris O'Brien Lifehouse (1)
2139 - Concord - Concord Repatriation General Hospital (1)
2305 - New Lambton Heights - John Hunter Children's Hospital (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
4224 - Tugun - Genesis Care Tugun - John Flynn Private Hospital (1)
2065 - Wollstonecraft - Melanoma Institute Australia - The Poche Centre (1)
6009 - Nedlands - One Clinical Research (1)
3004 - Melbourne, Southbank - Alfred Health (1)
3021 - St Albans - Western Health - Sunshine Hospital (1)
3168 - Clayton - Monash Medical Centre (1)
3199 - Frankston - Peninsula Health Frankston Hospital (1)
5042 - Bedford Park - Southern Oncology Clinical Research Unit (1)
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre (1)
3066 - Epping - Northern Hospital (1)
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital (1)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (1)
2217 - Kogarah - St George Hospital (1)
Cancer Type
Cancer
Solid tumour
Breast cancer
Lung cancer
Respiratory tract cancer
Thoracic cancer
Melanoma
Non-small cell lung cancer
Skin cancer
Central nervous system cancer
Gastrointestinal cancer
Glioblastoma
Glioma
Gynaecological cancer
High-grade glioma
Male genital cancers
Malignant glioma
Neurological cancer
Ovarian cancer
Pancreatic cancer
Pancreatobiliary cancer
Prostate cancer
Upper gastrointestinal cancer
Urogenital cancer
Cutaneous melanoma
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy